Fibrinolysis for intermediate-risk pulmonary embolism

N Engl J Med. 2014 Aug 7;371(6):579. doi: 10.1056/NEJMc1406283.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / therapeutic use*
  • Humans
  • Male
  • Pulmonary Embolism / drug therapy*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Heparin
  • Tissue Plasminogen Activator